<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">clinmed</journal-id><journal-title-group><journal-title xml:lang="ru">Клиническая медицина</journal-title><trans-title-group xml:lang="en"><trans-title>Clinical Medicine (Russian Journal)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0023-2149</issn><issn pub-type="epub">2412-1339</issn><publisher><publisher-name>ООО «Медицинское информационное агентство»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.30629/0023-2149-2026-104-1-31-41</article-id><article-id custom-type="elpub" pub-id-type="custom">clinmed-1355</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL INVESTIGATIONS</subject></subj-group></article-categories><title-group><article-title>Связь ишемической болезни сердца с нарушениями ритма сердца у мужчин трудоспособного возраста с ожирением</article-title><trans-title-group xml:lang="en"><trans-title>Association of coronary artery disease with cardiac arrhythmias in men of working age with obesity</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7220-4745</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Панова</surname><given-names>Е. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Panova</surname><given-names>E. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Панова Елена Ивановна — д-р мед. наук, доцент, профессор кафедры эндокринологии и внутренних болезней  </p><p>Нижний Новгород </p></bio><bio xml:lang="en"><p>Elena I. Panova — Doctor of Medical Sciences, Associate Professor, Professor of the Department of Endocrinology and Internal Diseases </p><p>Nizhny Novgorod </p></bio><email xlink:type="simple">elpanova2005@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8302-2218</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Морозова</surname><given-names>Е. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Morozova</surname><given-names>E. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Морозова Елена Павловна — канд. мед. наук, доцент кафедры эндокринологии и внутренних болезней  </p><p>Нижний Новгород </p></bio><bio xml:lang="en"><p>Elena P. Morozova — Candidate of Medical Sciences Associate Professor of the Department of Endocrinology and Internal Diseases </p><p>Nizhny Novgorod </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6240-5757</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Цыпленкова</surname><given-names>Н. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Tsyplenkova</surname><given-names>N. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Цыпленкова Наталия Сергеевна — канд. мед. наук, врач терапевтического отделения </p><p>Нижний Новгород </p></bio><bio xml:lang="en"><p>Nataliya S. Tsyplenkova — Candidate of Medical Sciences, doctor of the therapeutic department </p><p>Nizhny Novgorod </p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Приволжский исследовательский медицинский университет» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Privolzhsky Research Medical University of the Ministry of Health of the Russia</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФКУЗ «Медико-санитарная часть МВД России по Нижегородской области»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Medical and sanitary unit of the Ministry of Internal Affairs of Russia in the Nizhny Novgorod region</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>15</day><month>03</month><year>2026</year></pub-date><volume>104</volume><issue>1</issue><fpage>31</fpage><lpage>41</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Панова Е.И., Морозова Е.П., Цыпленкова Н.С., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Панова Е.И., Морозова Е.П., Цыпленкова Н.С.</copyright-holder><copyright-holder xml:lang="en">Panova E.I., Morozova E.P., Tsyplenkova N.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.clinmedjournal.com/jour/article/view/1355">https://www.clinmedjournal.com/jour/article/view/1355</self-uri><abstract><p>Цель. Изучить распространенность ИБС и структуру нарушений ритма при избыточной массе тела и ожирении у мужчин трудоспособного возраста, а также установить взаимосвязь между наличием аритмий и ИБС в зависимости от различных клинико-лабораторно-инструментальных факторов риска. Материал и методы. В исследование включено 184 пациента мужского пола в возрасте от 25 до 64 лет [44,4 ± 8,0], обратившихся для планового медицинского обследования и лечения. Больные разделены на 3 группы в зависимости от индекса массы тела (ИМТ) с последующим комплексным клинико-лабораторно-инструментальным обследованием и анализом результатов в группах. Статистическую обработку выполняли с использованием методов параметрического и непараметрического анализов на персональном компьютере с использованием статистических программ в среде Excel 97.0 и Statistic for Windows 6.0. Различия считали статистически значимыми при р &lt; 0,05. Результаты. Обследованы три группы пациентов в зависимости от значения ИМТ: I группа — 40 человек с нормальной массой тела (МТ), средний ИМТ 23,3 ± 1,3 кг/м2; II группа — 46 человек с избыточной МТ, средний ИМТ 27,3 ± 1,5 кг/м2; III группа — 98 пациентов с ожирением (ОЖ) 1-й–3-й степени, средний ИМТ 34,9 ± 5,0 кг/м2. Установлено, что повышение МТ ассоциируется с увеличением частоты ИБС: при нормальной МТ ИБС имели 10% больных, при избыточной МТ — 50,0%, при ОЖ — 58,2% ( I–II p &lt; 0,001; I–III p &lt; 0,001; II–III p &lt; 0,604), причем в группе пациентов в возрасте до 35 лет ИБС не наблюдалось, среди больных в возрасте 35–50 лет ее частота составила 23,9%, старше 50 лет — 52,9% (Рχ2 &lt; 0,001). Показано, что нарастание МТ сопровождается статистически значимым увеличением частоты парных наджелудочковых экстрасистол (НЖЭ), желудочковых экстрасистол (ЖЭ) &gt; 200 в сутки, аллоритмических ЖЭ и фибрилляции предсердий (ФП). При этом риск развития аритмий в зависимости от ИМТ увеличивается только при ассоциированной ИБС, наличие которой достоверно повышает относительный риск (ОР) ЖЭ в целом в 3,78 раз (р &lt; 0,001), ЖЭ высоких градаций — в 2,18 раз (р &lt; 0,002), частых ЖЭ — в 3,3 раз (р = 0,017), аллоритмических ЖЭ — в 4,13 раз (р = 0,007). В развитии ЖЭ в исследуемой группе могут играть роль такие потенцирующие факторы как: гипертрофия левого желудочка (ГЛЖ) (р = 0,038), диастолическая дисфункция ЛЖ (ДДЛЖ) (р = 0,032), низкий уровень холестерина липопротеидов высокой плотности сыворотки крови (ХС ЛПВП) (р = 0,029), а также превышающее референсные значения содержание адипонектина (А), которое прямо коррелировало с суточным количеством ЖЭ (r = + 0,34, p = 0,043). Заключение. Существует взаимосвязь между повышенной МТ и частотой развития таких аритмий как НЖЭ, ЖЭ, аллоритмическая ЖЭ и ФП по мере увеличения возраста пациентов. Однако эта закономерность свойственна лишь лицам с ИБС, наличие которой при ОЖ и избыточной МТ играет роль значимого фактора риска развития желудочковых аритмий, чего не выявлено относительно наджелудочковых (ФП, НЖЭ) нарушений ритма. Среди факторов риска, ассоциированных с развитием желудочковых нарушений ритма при ИБС и ОЖ, следует отметить диастолическую дисфункцию левого желудочка (ЛЖ), гипертрофию левого желудочка (ГЛЖ), низкий уровень холестерина липопротеидов высокой плотности (ХС ЛПВП) сыворотки крови, гиперадипонектинемию. </p></abstract><trans-abstract xml:lang="en"><p>The purpose is to study the prevalence of coronary heart disease and the structure of rhythm disturbances in overweight and obese men of working age, as well as to establish the relationship between the presence of arrhythmias and coronary heart disease, depending on various clinical, laboratory and instrumental risk factors. Material and methods. The study included 184 male patients aged 25 to 64 years [44.4 ± 8.0] who applied for routine medical examination and treatment. The patients were divided into 3 groups depending on body mass index (BMI), followed by a comprehensive clinical, laboratory and instrumental examination and analysis of the results in groups. Statistical processing was performed using parametric and nonparametric analysis methods on a personal computer using statistical programs in the environment Exel 97.0 and Statistica for Windows 6.0. The differences were considered statistically significant at p &lt; 0.05. Results. Three groups of patients were examined depending on the BMI value: group I — 40 people with normal body weight (BW), average BMI of 23.3 ± 1.3 kg/m2; group II — 46 people with excess BW, average BMI of 27.3 ± 1.5 kg/m2; group III — 98 people with obesity 1–3 degrees, average BMI 34.9 ± 5.0 kg/m2. It was found that an increase in BW is associated with an increase in the frequency of coronary artery disease (CAD): with normal BW — 10% of patients had CAD, with excessive BW — 50.0%, with obesity — 58.2% (I–II p &lt; 0.001; I–III p &lt; 0.001; II–III p &lt; 0.604), and in the group of patients with CAD was not observed before the age of 35, among patients aged 35-50 years, its frequency was 23.9%, over 50 years-52.9% (pχ2 &lt; 0.001). It has been shown that the increase in BW is accompanied by a statistically significant increase in the frequency of paired supraventricular extrasystoles  ( SVES), ventricular extrasystoles ( VES) &gt; 200 per day, allorhythmic VES and atrial fibrillation (AF). Moreover, the risk of arrhythmias, depending on BMI, increases only with associated CAD, the presence of which significantly increases the relative risk (RR) of VES in general by 3.78 times (p &lt; 0.001), high-grade VES by 2.18 times (p &lt; 0.002), frequent VES by 3.3 times (p = 0.017), allorhythmic VES by 4.13 times (p = 0.007). In the development of VES, such potentiating factors in the study group may play a role as: left ventricular hypertrophy (LVH) (p = 0.038), LV diastolic dysfunction (p = 0.032), low serum high density lipoprotein cholesterol (HDL) (p = 0.029), as well as an exceeding the reference values content of adiponectin (А), which directly correlated with the daily number of VES (r = +0.34, p = 0.043). Conclusion. There is a relationship between increased BW and the frequency of arrhythmias such as SVES, VES, allorhythmic VES and AF as the age of patients increases. However, this pattern is peculiar only to persons with CAD, the presence of which in case of obesity and excessive BW plays the role of a significant risk factor for the development of ventricular arrhythmias, which has not been revealed with respect to supraventricular (AF, SVES) rhythm disturbances. Among the risk factors associated with the development of ventricular arrhythmias in CAD and obesity, left ventricular diastolic dysfunction (LVDD), left ventricular hypertrophy (LVH), low serum high density lipoprotein cholesterol (HDL) and hyper adiponectinemia should be noted. </p></trans-abstract><kwd-group xml:lang="ru"><kwd>ожирение</kwd><kwd>избыточная масса тела</kwd><kwd>ишемическая болезнь сердца</kwd><kwd>нарушение ритма сердца</kwd><kwd>желудочковая экстрасистолия</kwd><kwd>липопротеиды высокой плотности</kwd><kwd>адипонектин</kwd></kwd-group><kwd-group xml:lang="en"><kwd>obesity</kwd><kwd>excessive body weight</kwd><kwd>coronary artery disease</kwd><kwd>cardiac rhythm disorders</kwd><kwd>ventricular extrasystole</kwd><kwd>high density lipoprotein cholesterol</kwd><kwd>adiponectin</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet. 2024;403(10431):1027–1050. DOI: 10.1016/S0140-6736(23)02750-2</mixed-citation><mixed-citation xml:lang="en">NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet. 2024;403(10431):1027–1050. DOI: 10.1016/S0140-6736(23)02750-2</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Алферова В.И., Мустафина С.В. Распространенность ожирения во взрослой популяции Российской Федерации (обзор литературы). Ожирение и метаболизм. 2022;19(1):96–105. DOI: 10.14341/omet12809</mixed-citation><mixed-citation xml:lang="en">Alferova V.I., Mustafina S.V. The prevalence of obesity in the adult population of the Russian Federation (literature review). Obesity and metabolism. 2022;19(1):96–105. (In Russ.). DOI: 10.14341/omet12809</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Дедов И.И., Шестакова М.В., Мельниченко Г.А., Мазурина Н.В., Андреева Е.Н., Бондаренко И.З. и др. Междисциплинарные клинические рекомендации «Лечение ожирения и коморбидных заболеваний». Ожирение и метаболизм. 2021;18(1):5–99. DOI: 10.14341/omet12714</mixed-citation><mixed-citation xml:lang="en">Dedov I.I., Shestakova M.V., Melnichenko G.A., Mazurina N.V., Andreeva E.N., Bondarenko I.Z. et al. Interdisciplinary Clinical Practice Guidelines “Management of obesity and its comorbidities”. Obesity and metabolism. 2021;18(1):5–99. (In Russ.). DOI: 10.14341/omet12714</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Li Chuanbao, Liu Huiruo, Xu Feng, Chen Yuguo. The role of lipotoxicity in cardiovascular disease. Emergency and Critical Care Medicine. 2022;2(4):214–218. DOI: 10.1097/EC9.0000000000000024</mixed-citation><mixed-citation xml:lang="en">Li Chuanbao, Liu Huiruo, Xu Feng, Chen Yuguo. The role of lipotoxicity in cardiovascular disease. Emergency and Critical Care Medicine. 2022;2(4):214–218. DOI: 10.1097/EC9.0000000000000024</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Kosmala W., Sanders P., Marwick T.H. Subclinical Myocardial Impairment in Metabolic Diseases. JACC: Cardiovasc. Imaging. 2017;10(6):692–703. DOI: 10.1016/j.jcmg.2017.04.001</mixed-citation><mixed-citation xml:lang="en">Kosmala W., Sanders P., Marwick T.H. Subclinical Myocardial Impairment in Metabolic Diseases. JACC: Cardiovasc. Imaging. 2017;10(6):692–703. DOI: 10.1016/j.jcmg.2017.04.001</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Nishida K. Inflammation and metabolic cardiomyopathy. Cardiovasc. Res. 2017;113(4):389–98. DOI: 10.1093/cvr/cvx012</mixed-citation><mixed-citation xml:lang="en">Nishida K. Inflammation and metabolic cardiomyopathy. Cardiovasc. Res. 2017;113(4):389–98. DOI: 10.1093/cvr/cvx012</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Čolak E.; Pap D. The role of oxidative stress in the development of obesity and obesity-related metabolic disorders. J. Med. Biochem. 2021;40:1–9. DOI: 10.5937/jomb0-24652</mixed-citation><mixed-citation xml:lang="en">Čolak E.; Pap D. The role of oxidative stress in the development of obesity and obesity-related metabolic disorders. J. Med. Biochem. 2021;40:1–9. DOI: 10.5937/jomb0-24652</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Полонская Я.В., Каштанова Е.В., Стахнева Е.М., Шрамко В.С., Садовский Е.В., Стрюкова Е.В., Рагино Ю.И. Окислительноантиоксидантные изменения в крови у молодых людей с ранней ишемической болезнью сердца на фоне абдоминального ожирения. Российский кардиологический журнал. 2022;27(6):64–69 DOI: 10.15829/1560-4071-2022-5055.</mixed-citation><mixed-citation xml:lang="en">Polonskaya Ya.V., Kashtanova E.V., Stakhneva E.M., Shramko V.S., Sadovsky E.V., Stryukova E.V., Ragino Yu.I. Oxidative and antioxidant changes in blood of young people with premature coronary artery disease and abdominal obesity. Russian Journal of Cardiology. 2022;27(6):64–69. (In Russ.). DOI: 10.15829/1560-4071-2022-5055.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Гарбузова Е.В., Худякова А.Д., Алексеев С.Е. Ассоциации адипокинов с ишемической болезнью сердца у людей молодого и среднего возраста. Атеросклероз. 2023; 19 (4): 444–456. DOI: 10.52727/2078-256X-2023-19-4-444-456</mixed-citation><mixed-citation xml:lang="en">Garbuzova E.V., Khudiakova A.D., Alekseev S.E. Associations of adipokines with coronary heart disease in young and middleaged people. Ateroscleroz. 2023;19(4):444–456. (In Russ.) DOI: 10.52727/2078-256X-2023-19-4-444-456</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Шрамко В.С., Каштанова Е.В., Полонская Я.В., Стахнева Е.М., Рагино Ю.И. Адипокино-цитокиновый профиль крови у мужчин с коронарным атеросклерозом на фоне избыточной массы тела. Атеросклероз. 2023;19(3):332–334. DOI: 10.52727/2078-256X-2023-19-3-332-334</mixed-citation><mixed-citation xml:lang="en">Shramko V.S., Kashtanova E.V., Polonskaya Ya.V., Stakhneva E.M., Ragino Yu.I. Adipokineadipocytokines profile in men with coronary atherosclerosis and overweight. Aterosсleroz. 2023;19(3):332–334. (In Russ.). DOI: 10.52727/2078-256X-2023-19-3-332-334</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Лавренова Е.А., Драпкина О.М. Инсулинорезистентность при ожирении: причины и последствия. Ожирение и метаболизм. 2020;17(1):48–55. DOI: 10.14341/omet9759</mixed-citation><mixed-citation xml:lang="en">Lavrenova E.A., Drapkina O.M. Insulin resistance in obesity: pathogenesis and effects. Obesity and metabolism. 2020;17(1):48–55. (In Russ.) DOI: 10.14341/omet9759</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Азимова М.О., Блинова Н.В., Жернакова Ю.В., Чазова И.Е. Ожирение как предиктор сердечно-сосудистых заболеваний: роль локальных жировых депо. Системные гипертензии. 2018;15(3):39– 43. DOI: 10.26442/2075-082X_2018.3.39-43</mixed-citation><mixed-citation xml:lang="en">Azimova M.O., Blinova N.V., Zhernakova Yu.V., Chazova I.E. Obesity as a predictor for cardiovascular disease development: role of localized fat depot. Systemic Hypertension. 2018;15(3):39–43. (In Russ.). DOI: 10.26442/2075-082X_2018.3.39-43</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Haffar T., Bérubé-Simard F., Bousette N. Impaired fatty acid oxidation as a cause for lipotoxicity in cardiomyocytes. Biochem. Biophys. Re.s Commun. 2015;468(1–2):73–78. DOI: 10.1016/j.bbrc.2015.10.162</mixed-citation><mixed-citation xml:lang="en">Haffar T., Bérubé-Simard F., Bousette N. Impaired fatty acid oxidation as a cause for lipotoxicity in cardiomyocytes. Biochem. Biophys. Re.s Commun. 2015;468(1–2):73–78. DOI: 10.1016/j.bbrc.2015.10.162</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Alpert M.A., Karthikeyan K., Abdullah O., Ghadban R. Obesity and cardiac remodeling in adults: mechanisms and clinical implications. Prog. Cardiovasc Dis. 2018; 61(2):114–123. DOI: 10.1016/j.pcad.2018.07.012</mixed-citation><mixed-citation xml:lang="en">Alpert M.A., Karthikeyan K., Abdullah O., Ghadban R. Obesity and cardiac remodeling in adults: mechanisms and clinical implications. Prog. Cardiovasc Dis. 2018; 61(2):114–123. DOI: 10.1016/j.pcad.2018.07.012</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Shu H., Cheng J., Li N. et al. Obesity and atrial fibrillation: a narrative review from arrhythmogenic mechanisms to clinical significance. Cardiovascular Diabetology. 2023;22:192. DOI: 10.1186/s12933-023-01913-</mixed-citation><mixed-citation xml:lang="en">Shu H., Cheng J., Li N. et al. Obesity and atrial fibrillation: a narrative review from arrhythmogenic mechanisms to clinical significance. Cardiovascular Diabetology. 2023;22:192. DOI: 10.1186/s12933-023-01913-</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Урясьев О.М., Соловьева А.В., Ческидов А.В., Вулех В.М., Филимонова А.А. Роль кардиальных депо жировой ткани в прогнозировании риска развития пароксизмальной формы фибрилляции предсердий у пациентов с ишемической болезнью сердца и артериальной гипертензией. Международный журнал сердца и сосудистых заболеваний. 2023;38(11):18–26. DOI: 10.24412/2311-1623-2023-38-18-26</mixed-citation><mixed-citation xml:lang="en">Uryasiev O.M, Solovyova A.V, Cheskidov A. V., Vulekh V.M, Filimonova A. A. The role of cardiac adipose tissue depots in assessing the risk of paroxysmal atrial fibrillation in patients with coronary heart dis ease and arterial hypertension. International Journal of Heart and Vascular Diseases. 2023;38(11):18–26. (In Russ.). DOI: 10.24412/2311-1623-2023-38-18-26</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Lavie C.J., Pandey A., Lau D.H., Alpert M.A., Sanders P. Obesity and atrial fibrillation prevalence, pathogenesis, and prognosis: effects of weight loss and exercise. J Am Coll Cardiol. 2017;70(16):2022–2035. DOI: 10.1016/j.jacc.2017.09.002</mixed-citation><mixed-citation xml:lang="en">Lavie C.J., Pandey A., Lau D.H., Alpert M.A., Sanders P. Obesity and atrial fibrillation prevalence, pathogenesis, and prognosis: effects of weight loss and exercise. J Am Coll Cardiol. 2017;70(16):2022–2035. DOI: 10.1016/j.jacc.2017.09.002</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Тарасова И.В., Верткин А.Л. Роль эпикардиальной жировой ткани в развитии фибрилляции предсердий: обзор литературы. Лечащий врач. 2024;7(27):17–22. DOI: 10.51793/OS.2024.27.7.002</mixed-citation><mixed-citation xml:lang="en">Tarasova I.V., Vertkin A.L. The role of epicardial adipose tissue in the development of atrial fibrillation: a literature review. Lechaschi Vrach. 2024;7(27):17–22. (In Russ.). DOI: 10.51793/OS.2024.27.7.002</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Sandhu R., Conen D., Tedrow U., Fitzerald K., Pradham A., Ridker M. et al. Predisposing factors associated with development of persistent compared with paroxysmal atrial fibrillation. J. Am. Heart Assoc. 2014;3: e000916. DOI: 10.1161/JAHA.114.000916</mixed-citation><mixed-citation xml:lang="en">Sandhu R., Conen D., Tedrow U., Fitzerald K., Pradham A., Ridker M. et al. Predisposing factors associated with development of persistent compared with paroxysmal atrial fibrillation. J. Am. Heart Assoc. 2014;3: e000916. DOI: 10.1161/JAHA.114.000916</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Mozos I. Arrhythmia risk and obesity. Journal of Molecular and Genetic Medicine. 2014;s1:006. DOI:10.4172/1747-0862.s1-006</mixed-citation><mixed-citation xml:lang="en">Mozos I. Arrhythmia risk and obesity. Journal of Molecular and Genetic Medicine. 2014;s1:006. DOI:10.4172/1747-0862.s1-006</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Клинические рекомендации. Артериальная гипертензия у взрослых. 2020–2021–2022 (20.01.2023). Утверждены МЗ РФ. URL: kr-po-ag-22g.pdf (gkb05.ru)</mixed-citation><mixed-citation xml:lang="en">Clinical guidelines. Arterial hypertension in adults. 2020–2021–2022 (20.01.2023).Approved by the Ministry of Health of the Russian Federation. (In Russian). URL: kr-po-ag-22g.pdf (gkb05.ru)</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Клинические рекомендации. Нарушения липидного обмена. 2023–2024–2025 (15.02.2023). Утверждены МЗ РФ. URL: 2023_narusheniya_lo.pdf</mixed-citation><mixed-citation xml:lang="en">Clinical recommendations. Disorders of lipid metabolism. 2023–2024–2025 (15.02.2023). Approved by the Ministry of Health of the Russian Federation. (In Russian). [Electronic resource]. URL: 2023_narusheniya_lo.pdf</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Ascaso J.F., Pardo S., Real J.T., Lorente R.I., Priego A., Carmena R. Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care. 2003;26(12):3320–3325. DOI: 10.2337/diacare.26.12.3320</mixed-citation><mixed-citation xml:lang="en">Ascaso J.F., Pardo S., Real J.T., Lorente R.I., Priego A., Carmena R. Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care. 2003;26(12):3320–3325. DOI: 10.2337/diacare.26.12.3320</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Диагностика, лечение, профилактика ожирения и ассоциированных с ним заболеваний (национальные клинические рекомендации) . СПб., 2017. URL: https://library.mededtech.ru/rest/documents/Ozhirenie_klin_rek_proekt/?ysclid=m297i0cegc305724157</mixed-citation><mixed-citation xml:lang="en">Diagnosis, treatment, and prevention of obesity and related diseases (national clinical guidelines). St. Petersburg, 2017. (In Russ.). [Electronic resource]. URL: https://library.mededtech.ru/rest/documents/Ozhirenie_klin_rek_proekt/?ysclid=m297i0cegc305724157</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Национальные российские рекомендации по применению методики Холтеровского мониторирования в клинической практике. Российский кардиологический журнал. 2014;106(2):6–71. URL: natsionalnye-rossiyskie-rekomendatsiipo-primeneniyu-metodiki-holterovskogo-monitorirovaniya-vklinicheskoy-praktike.pdf</mixed-citation><mixed-citation xml:lang="en">National Russian guidelines on application of the methods of Holter monitoring in clinical practice. Russ. J. Cardiol. 2014;106(2):6– 71. (In Russ.). URL: natsionalnye-rossiyskie-rekomendatsiipo-primeneniyu-metodiki-holterovskogo-monitorirovaniya-vklinicheskoy-praktike.pdf</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Диагностика и лечение нарушений ритма сердца и проводимости. Клинические рекомендации. Кардиологический вестник. 2014; Часть I и II(2, 3):3–52. URL: 9bb5d5d8-6b31-4e74-b506-a3fa00dcced6 (doktornarabote.ru)</mixed-citation><mixed-citation xml:lang="en">Guidelines on diagnosis and management of arrhythmias. Russian Cardiology Bulletin. 2014; Part I, II(2, 3):3–52. (In Russ.). [Electronic resource]. URL: 9bb5d5d8-6b31-4e74-b506-a3fa00dcced6 (doktornarabote.ru)</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Шляхто Е.В. Кардиология. Национальное руководство. Краткое издание/под ред. Е.В. Шляхто. 2-е изд., перераб. и доп. Москва: ГЭОТАР-Медиа. 2023:816. URL: https://www.rosmedlib.ru/book/ISBN9785970475379.html</mixed-citation><mixed-citation xml:lang="en">Shlyakhto E.V. Cardiology. National guidance. Short edition/ edited by E.V. Shlyakhto. 2nd ed., reprint. and add. Moscow: GEOTAR-Media. 2023:816. (In Russ.). [Electronic resource]. URL: https://www.rosmedlib.ru/book/ISBN9785970475379.html</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Трансторакальная эхокардиография у взрослых: методические рекомендации / сост. Д.А. Дорошенко, М.А. Беневская, Н.Н. Ветшева. Серия «Лучшие практики лучевой и инструментальной диагностики». Москва: ГБУЗ «НПКЦ ДиТ ДЗМ». 2020;54:40.</mixed-citation><mixed-citation xml:lang="en">ТTransthoracic echocardiography in adults: methodological recommendations. Comp.: D.A. Doroshenko, M.A. Benevskaya, N.N. Vetsheva. The series “The best practices of radiodiagnostics and instrumental diagnostics”. Moscow: 2020;54:40. ( In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Sherif N., Smiseth O., Appleton Ch. et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J. Am. Soc. Echocardiogr. 2016;29(4):277–314. DOI: 10.1016/j.echo.2016.01.011</mixed-citation><mixed-citation xml:lang="en">Sherif N., Smiseth O., Appleton Ch. et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J. Am. Soc. Echocardiogr. 2016;29(4):277–314. DOI: 10.1016/j.echo.2016.01.011</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Galderisi M., Cosyns B., Edvardsen Th. et al. Standardization of adult transthoracic echocardiography reporting in agreement with recent chamber quantification, diastolic function, and heart valve disease recommendations: an expert consensus document of the European Association of Cardiovascular Imaging. European Heart Journal. Cardiovascular Imaging. 2017;18(12):1301–1310. URL: DOI: 10.1093/ehjci/jex244</mixed-citation><mixed-citation xml:lang="en">Galderisi M., Cosyns B., Edvardsen Th. et al. Standardization of adult transthoracic echocardiography reporting in agreement with recent chamber quantification, diastolic function, and heart valve disease recommendations: an expert consensus document of the European Association of Cardiovascular Imaging. European Heart Journal. Cardiovascular Imaging. 2017;18(12):1301–1310. URL: DOI: 10.1093/ehjci/jex244</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Халафян А.А. Промышленная статистика. Контроль качества, анализ процессов, планирование экспериментов в пакете STATISTICA: учебник. Либроком, 2017:384.</mixed-citation><mixed-citation xml:lang="en">Khalafyan A. A. Industrial statistics. Quality control, process analysis, experiment planning in the STATISTICA package: textbook. Librocom, 2017:384. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Macheret F., Bartz T., Djousse L., et al.Higher circulating adiponectin levels are associated with increased risk of atrial fibrillation in older adults. Heart. 2015;17(101):1368–1374. DOI: 10.1136/heartjnl-2014-307015</mixed-citation><mixed-citation xml:lang="en">Macheret F., Bartz T., Djousse L., et al.Higher circulating adiponectin levels are associated with increased risk of atrial fibrillation in older adults. Heart. 2015;17(101):1368–1374. DOI: 10.1136/heartjnl-2014-307015</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Худякова А.Д., Полонская Я.В., Щербакова Л.В., Кузьминых Н.А., Шрамко В.С., Каштанова Е.В., Рагино Ю.И. Ассоциации циркулирующих адипокинов и ишемической болезни сердца у лиц молодого возраста. Кардиоваскулярная терапия и профилактика. 2024;23(5):6–15. DOI: 10.15829/1728-8800-2024-3965. EDN: NCGYJW</mixed-citation><mixed-citation xml:lang="en">Khudiakova A.D., Polonskaya Y.V., Shcherbakova L.V., Shramko V.S., Kuzminykh N.A., Kashtanova E.V., Ragino Yu.I. Associations of circulating adipokines and coronary artery disease in young adults. Cardiovascular Therapy and Prevention. 2024;23(5):6–15. (In Russ.) DOI: 10.15829/1728-8800-2024-3965. EDN: NCGYJW</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Подзолков В.И.,Тарзиманова А.И.,Гатаулин Р.Г.,Оганесян К.А., Лобова Н.В. Роль ожирения в развитии фибрилляции предсердий: современное состояние проблемы. Кардиоваскулярная терапия и профилактика. 2019;18(4):109–114. DOI: 10.15829/1728-8800-2019- 4-109-114</mixed-citation><mixed-citation xml:lang="en">Podzolkov V.I., Tarzimanova A.I., Gataulin R.G., Oganesyan K.A., Lobova N.V. The role of obesity in the development of atrial fibrillation: current problem status. Cardiovascular Therapy and Prevention. 2019;18(4):109–114. (In Russ.). DOI: 10.15829/1728-8800-2019- 4-109-114</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Perju-Dumbrava D., Chiroban O., Radu С. Obesity and Overweight Risk Factors in Sudden Death Due to Cardiovascular Causes: A Case Series. Iran J. Public. Health. 2017;46(6):856–857. 36. Aune D., Schlesinger S., Norat T., Riboli E. Body mass index, abdominal fatness, and the risk of sudden cardiac death: a systematic review and dose response meta-analysis of prospective studies. European Journal of Epidemiology. 2018;33:711–722.</mixed-citation><mixed-citation xml:lang="en">Perju-Dumbrava D., Chiroban O., Radu С. Obesity and Overweight Risk Factors in Sudden Death Due to Cardiovascular Causes: A Case Series. Iran J. Public. Health. 2017;46(6):856–857. 36. Aune D., Schlesinger S., Norat T., Riboli E. Body mass index, abdominal fatness, and the risk of sudden cardiac death: a systematic review and dose response meta-analysis of prospective studies. European Journal of Epidemiology. 2018;33:711–722.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Клинические рекомендации. Ожирение. 2020 (17.02.2021). Утверждены МЗ РФ. URL: ozhirenie_vzroslye.pdf (endocrincentr.ru)</mixed-citation><mixed-citation xml:lang="en">Clinical guidelines. Fatness. 2020 (17.02.2021). Approved by the Ministry of Health of the Russian Federation. (In Russ.). [Electronic resource]. URL: ozhirenie_vzroslye.pdf (endocrincentr.ru)</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Willet W., Manson J.E., Stampfer M.J., Colditz G.A., Rosner B., Speizer F.E., Hennekens C.H. Weight, weight change, and coronary heart disease in women. Risk within the normal weight range. JAMA. 1995;273:461–465. DOI: 10.1001/jama.1995.03520300035033</mixed-citation><mixed-citation xml:lang="en">Willet W., Manson J.E., Stampfer M.J., Colditz G.A., Rosner B., Speizer F.E., Hennekens C.H. Weight, weight change, and coronary heart disease in women. Risk within the normal weight range. JAMA. 1995;273:461–465. DOI: 10.1001/jama.1995.03520300035033</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Брель Н.К., Груздева О.В., Коков А.Н., Масенко В.Л., Дылева Ю.А., Белик Е.В., Барбараш О.Л. Взаимосвязь висцерального ожирения и коронарного кальциноза при ишемической болезни сердца. Терапевтический архив. 2021;93(12):1428–1434. DOI: 10.26442/00403.660.2021.12.201277</mixed-citation><mixed-citation xml:lang="en">Brel N.K., Gruzdeva O.V., Kokov A.N., Masenko V.L., Dyleva Yu.A., Belik E.V., Barbarash O.L. Relationship of visceral obesity and coronary calcinosis in ischemic heart disease. Therapeutic Archive. 2021;93(12): 428–1434. (In Russ.). DOI: 10.26442/00403.660.2021.12.201277</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Вербовой А.Ф., Вербовая Н.И., Долгих Ю.А. Ожирение — основа метаболического синдрома. Ожирение и метаболизм. 2021;18(2):142–149. DOI: 10.14341/omet12707</mixed-citation><mixed-citation xml:lang="en">Verbovoy A.F., Verbovaya N.I., Dolgikh Yu.A. Obesity is the basis of metabolic syndrome. Obesity and metabolism. 2021;18(2):142–149. (In Russian). DOI: 10.14341/omet12707</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Цыпленкова Н.С. Особенности сердечного ритма у мужчин трудоспособного возраста с ожирением и артериальной гипертензией. Ожирение и метаболизм. 2016;13(1):30–35. DOI: 10.14341/omet2016130-35</mixed-citation><mixed-citation xml:lang="en">Tsyplenkova N.S., Panova E.I. Heart rate features among men of working age with obesity and hypertension. Obesity and metabolism. 2016;13(1):30–35. (In Russ.). DOI: 10.14341/omet2016130-35</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Wu Z.J., Cheng Y.J., Gu W.J., Aung H.L. Adiponectin is asso ciated with increased mortality in patients with already estab lished cardiovascular disease: A systematic review and metaanalysis. Metabolism. 2014;63(9):1157–66. DOI: 10.1016/j.metabol.2014.05.001</mixed-citation><mixed-citation xml:lang="en">Wu Z.J., Cheng Y.J., Gu W.J., Aung H.L. Adiponectin is asso ciated with increased mortality in patients with already estab lished cardiovascular disease: A systematic review and metaanalysis. Metabolism. 2014;63(9):1157–66. DOI: 10.1016/j.metabol.2014.05.001</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Гаврилова Н.Е., Метельская В. А., Бойцов С.А. и др. Маркеры нарушения метаболизма висцеральной жировой ткани у пациентов с коронарным атеросклерозом в зависимости от наличия сахарного диабета 2-го типа. Терапевтический архив. 2015;87(10):31–36. DOI: 10.17116/terarkh2015871031-36.</mixed-citation><mixed-citation xml:lang="en">Gavrilova N.E., MetelskayaV.A., Boytsov S.A. et al. Markers of visceral adipose tissue metabolic abnormalities in patients with coronary atherosclerosis in relation to the presence of type 2 diabetes mellitus. Therapeutic Archive. 2015;87(10):31–36. (In Russ.). DOI: 10.17116/terarkh2015871031-36.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Гиоева З.М., Богданов А.Р., Залетова Т.С., Богданова А.А. Ожирение как фактор риска развития хронической сердечной недостаточности (литературный обзор). Доктор.Ру. 2017;10 (139):21– 25.</mixed-citation><mixed-citation xml:lang="en">Gioeva Z.M., Bogdanov A. R., Zaletova T. S., Bogdanova A. A. Obesity as a Risk Factor for Chronic Heart Failure: a Review of the Literature. Doctor.Ru. 2017;10 (139):21–25. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Логачева И.В., Рязанова Т.А., Макарова В.Р., Авзалова Ф.Р., Максимов Н.И. Ремоделирование сердца у больных с избыточной массой тела и ожирением при коморбидной кардиальной патологии. Российский кардиологический журнал. 2017;4(144):40– 46. DOI: 10.15829/1560-4071-2017-4-40-46</mixed-citation><mixed-citation xml:lang="en">Logacheva I.V., Ryazanova T.A., Makarova V.R., Avzalova F.R., Maksimov N.I. Heart remodeling in overweight and odesity with cardiac comorbidities. Russ. J. Cardiol. 2017;(4):40–46. (In Russ.). DOI: 10.15829/1560-4071-2017-4-40-46</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
